Prostatic Intraepithelial Neoplasia is Risk Factor for Adenocarcinoma: Predictive Accuracy in Needle Biopsies

The Journal of Urology

Volumn 154, Issue 4, 1995, Pages 1295-1299

  Davidson, Deborah ^a   Bostwick, David G ^a   Qian, Junqi ^a   Wollan, Peter C ^a   Oesterling, Joseph E ^a   Rudders, Richard A ^a   Siroky, Mike ^a   Stilmant, Magda ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; RECTUM; RETROSPECTIVE STUDY; RISK FACTOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COMPARATIVE STUDY; EPITHELIUM; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029164685     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66840-X     Document Type: Article

References (42)

1. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer.
2. Intraductal dysplasia: a premalignant lesion of the prostate.
3. Prostatic intraepithelial neoplasia (PIN): current concepts
4. Introductory remarks and workshop summary
5. Microcarcinoma of the prostate: its association with duct-acinar dysplasia.
6. Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma.
7. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis.
8. Mucin in severe dysplasia in the prostate.
9. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.
10. Quantitation of prostatic intra-epithelial neoplasia
11. Quantitative analysis of prostatic intraepithelial neoplasia on tissue sections.
12. Prostatic intra-epithelial neoplasia.
13. Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.
14. Computerized static DNA ploidy analysis of prostatic intraepithelial neoplasia.
15. Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma.
16. DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate.
17. Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis.
18. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study.
19. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
20. c-erbB-2 oncogene expression in prostatic intraepithelial neoplasia: mounting evidence for a precursor role.
21. Large acinar atypical hyperplasia and carcinoma of the prostate.
22. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.
23. Follow-up aspiration biopsies for dysplasia of the prostate
24. Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy
25. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy.
26. Significance of high grade prostatic intraepithelial neoplasia on needle biopsy.
27. DNA distribution in the prostate
28. Architectural patterns of high-grade prostatic intraepithelial neoplasia.
29. Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions.
30. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia
31. Evaluation of transrectal ultrasound in the early detection of prostate cancer.
32. Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinoma.
33. Transrectal ultrasound screening for prostatic adenocarcinoma with histopathologic correlation. Factors affecting specificity.
34. Implications of small, peripheral hypoechoic lesions in endorectal US of the prostate.
35. Prostate-specific antigen and premalignant change: implications for early detection.
36. Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?
37. Interobserver variability in the diagnosis of high grade prostatic intraepithelial neoplasia and adenocarcinoma
38. Prostatic intraepithelial neoplasia: inter-observer variability in grading
39. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies: indications for repeat biopsy
40. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland
41. Histopathology of the premalignant process.
42. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials